STABLE FORMULATIONS COMPRISING A BISPECIFIC BCMA/CD3 ANTIBODY | Patent Publication Number 20230279136

US 20230279136 A1
Patent Number-
Application Number18053904
Filled DateNov 9, 2022
Priority DateNov 10, 2021
Publication DateSep 7, 2023
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsMatthew Joseph Mistilis
Shyamal Choudhari
Salman Muzammil
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.